SCHEMBL7674201

SCHEMBL7674201

CC(=O)N1C=NC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6251461 0.71 SMN1; SMN2 (0.40)
SCHEMBL296651 0.70
SCHEMBL7453607 0.67
SCHEMBL4788208 0.64
SCHEMBL5969104 0.57 NOTUM (0.32)
SCHEMBL6617171 0.57
SCHEMBL16541693 0.56
SCHEMBL310712 0.56
SCHEMBL1208896 0.56
SCHEMBL17891935 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6417185-B1 HETEROCYCLIC ENZYME INHIBITORS CHIRON CORPORATION 2002-07-09 US disclosed
EP-0379428-B1 IMPROVED METHOD FOR THE EXPRESSION OF BIOTIN IN BACILLUS SPHAERICUS TRANSGENE S.A. (FR) 1993-10-06 EP disclosed
EP-0379428-A1 Improved method for the expression of biotin in bacillus sphaericus TRANSGENE S.A. (FR) 1990-07-25 EP disclosed